Acyclovir for Injection 250mg
Pack Sizes Available
Product Description
Technical Specifications
- Active Ingredient: Acyclovir Sodium USP equivalent to 250mg Acyclovir per vial
- Dosage Form: Lyophilized powder for injection
- Drug Class: Synthetic nucleoside analog antiviral
- Reconstitution: 10ml Sterile Water for Injection USP, yields 25mg/ml
- Route of Administration: Intravenous infusion
- Storage Conditions: Store between 15-25 degrees Celsius, protect from moisture
Acyclovir injection is used to treat severe herpesvirus infections including herpes simplex encephalitis, severe mucocutaneous herpes simplex infections, disseminated neonatal herpes, and varicella-zoster complications, particularly in patients who cannot take oral medication or need rapid antiviral action.
Acyclovir is a synthetic nucleoside analog that is preferentially activated inside cells infected by herpes simplex or varicella-zoster virus through a viral enzyme, and the activated form then inhibits viral DNA polymerase and terminates viral DNA chain growth, stopping viral replication.
The vial is reconstituted with 10ml of Sterile Water for Injection USP, producing a solution containing 25mg of acyclovir per ml, which is then further diluted in an appropriate intravenous fluid before administration as directed in the package insert.
The 250mg strength allows more precise dosing for lower body weight patients, particularly neonates and small children, without requiring partial use of a larger vial.
The vial should be stored between 15 to 25 degrees Celsius, protected from moisture, until it is reconstituted for use.
Yes, we regularly supply this strength to pediatric and neonatal hospital pharmacies, and our team can advise on packaging and documentation suited to specialized pediatric procurement requirements.
Acyclovir for Injection 500mg
The 500mg strength is where Acyclovir for Injection earns its place as a genuine hospital workhorse, the dose most commonly reached for when treating adult patients with severe herpes simplex or varicella-zoster infections that demand fast, dependable intravenous therapy. Whether that is a case of herpes encephalitis, severe genital herpes in an immunocompetent patient, or complications from shingles in someone whose immune system is already compromised, this is the strength most hospital protocols are built around. Acyclovir remains one of the more elegantly targeted antivirals available, precisely because it depends on a viral enzyme to activate itself inside infected cells, largely sparing healthy tissue from the same effect. Once active, it blocks the viral DNA polymerase and halts replication of the herpes virus at the molecular level. Despite decades on the market and newer antivirals entering the field, this mechanism has kept Acyclovir relevant across pediatric, adult, and geriatric hospital populations alike. Sara Wellness has supplied antiviral injectables like this one to hospital networks and distributors across multiple continents for fifteen years, and one lesson that has stuck with us the whole way through is that demand for antivirals rarely follows a predictable calendar. A shingles outbreak in a nursing home, an unexpected cluster of encephalitis cases, or simply a hospital rebuilding its critical care reserve after a tender cycle can all create sudden spikes in order volume, and a supplier who cannot respond quickly is a liability rather than a partner. We source this product from GMP-certified manufacturing facilities in India and keep a direct line between our export desk and the procurement teams we work with, so when volumes need to shift quickly, that conversation happens fast and without unnecessary back and forth. Our MOQs work for hospital pharmacies maintaining a standing reserve as well as distributors placing larger, tender-driven orders on a fixed schedule. Every consignment ships with certificate of analysis, GMP compliance documentation, and export paperwork prepared according to your destination country's specific regulatory expectations, because a held-up shipment of an antiviral needed for a severe infection is not a problem anyone wants to explain to a hospital's infectious disease team. If your formulary needs a dependable source for Acyclovir 500mg, or you are simply looking to diversify your antiviral supply chain, reach out with your target market and volume requirements and we will respond with current pricing and realistic delivery timelines based on actual production capacity.
Acyclovir Tablets IP 400mg
Twice-daily dosing changes everything about whether a patient actually completes a long treatment course, and that's precisely the role the 400mg Acyclovir tablet plays. Where the 200mg strength asks for five doses a day, this strength is built around the twice-daily regimens used for chronic suppressive therapy, a meaningfully easier ask for someone managing recurrent outbreaks over months rather than days. Each tablet contains 400mg of Acyclovir, working through the same mechanism across every strength in the range: selective inhibition of viral DNA polymerase after activation inside an infected cell, which halts replication of herpes simplex virus and varicella-zoster virus without meaningfully affecting healthy, uninfected cells. That selectivity is a large part of why Acyclovir has stayed such a well-tolerated antiviral across decades of widespread global use. This strength is commonly used for chronic suppressive therapy in patients with frequent recurrent genital herpes, typically dosed at 400mg twice daily for extended periods, sometimes up to twelve months before re-evaluation. It's also used in episodic treatment regimens for recurrent outbreaks and in various treatment protocols for herpes-related conditions where a more moderate, twice-daily dose fits the clinical picture better than the higher-frequency 200mg schedule. For a distributor stocking a complete antiviral range, the 400mg strength tends to be the highest-volume mover of the three Acyclovir options simply because chronic suppressive therapy accounts for a large share of ongoing prescriptions, compared to the shorter, acute-episode courses that the other strengths are more often used for. We manufacture this strength to WHO-GMP standards alongside the 200mg and 800mg tablets, with contract manufacturing available under a buyer's own brand. Fifteen years of exporting antiviral formulations from India means this product ships with complete stability and bioequivalence documentation, not a partial file.
Acyclovir Tablets IP 200mg
Herpes infections don't follow a single dosing pattern, which is why Acyclovir comes in three separate tablet strengths rather than one. The 200mg tablet is the workhorse of that range, built around a dosing regimen that asks for more frequent, smaller doses rather than fewer, larger ones, matched to how certain herpes treatment protocols are actually structured. Each tablet contains 200mg of Acyclovir, a synthetic purine nucleoside analogue with activity against herpes simplex virus types 1 and 2, along with varicella-zoster virus. Once inside a virus-infected cell, Acyclovir is converted to its active triphosphate form, which then inhibits viral DNA polymerase and gets incorporated into the growing viral DNA chain, effectively stopping viral replication in its tracks. Because this activation step depends on a viral enzyme, the drug is selectively active against infected cells rather than healthy ones, which is part of why it's remained a well-tolerated antiviral across decades of use. This strength is indicated for the treatment of initial and recurrent genital herpes episodes, where dosing regimens commonly call for 200mg taken five times daily for a defined treatment course, and for chickenpox treatment in appropriate patients. The frequent dosing schedule at this strength reflects Acyclovir's relatively short half-life and the need to maintain effective drug levels between doses. Acyclovir remains one of the most established antivirals in any pharmaceutical export portfolio, with steady, predictable demand across nearly every market given how common herpes simplex and varicella-zoster infections are worldwide. It's a category where consistent, uninterrupted supply matters more to a distributor than aggressive pricing on a single shipment. We manufacture all three Acyclovir tablet strengths to WHO-GMP standards, giving buyers a complete dosing range to offer prescribers rather than a single SKU. Contract manufacturing under a buyer's own brand is available, backed by fifteen years of exporting antiviral formulations from India with documentation built for the destination market's actual registration requirements.